Chronic hepatitis C: future treatment
Astrid Wendt, Xavier Adhoute, Paul Castellani, Valerie Oules, Christelle Ansaldi, Souad Benali, Marc BourlièreDepartment of Hepato-Gastroenterology, Hôpital Saint-Joseph, Marseille, FranceAbstract: The launch of first-generation protease inhibitors (PIs) is a major step forward...
Guardado en:
Autores principales: | Wendt A, Adhoute X, Castellani P, Oules V, Ansaldi C, Benali S, Bourlière M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6b217c61852545d88fefd58686a4d89a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Management of chronic hepatitis C virus infection in patients with end-stage renal disease: a review
por: Aguirre Valadez J, et al.
Publicado: (2015) -
Pazopanib for the treatment of soft-tissue sarcoma
por: Heudel P, et al.
Publicado: (2012) -
Multiscale model of hepatitis C virus dynamics in plasma and liver following combination therapy
por: Xavier Woot de Trixhe, et al.
Publicado: (2021) -
Chronic fluoxetine treatment increases daytime melatonin synthesis in the rodent
por: Gillian W Reierson, et al.
Publicado: (2009) -
Analysis of factors affecting rehospitalization of patients with chronic kidney disease after educational hospitalization
por: Kose E, et al.
Publicado: (2014)